Sheetal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 09-12-2024
- Paid Up Capital ₹ 0.20 M
as on 09-12-2024
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.81 M
as on 09-12-2024
- Revenue 26.52%
(FY 2022)
- Profit -1.38%
(FY 2022)
- Ebitda -37.86%
(FY 2022)
- Net Worth 25.52%
(FY 2022)
- Total Assets 6.53%
(FY 2022)
About Sheetal Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹3.81 M.
Rajni Goel, Shital Agrawal, Nisha Devi, and Eight other members serve as directors at the Company.
- CIN/LLPIN
U24231UP1996PTC019631
- Company No.
019631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bahraich, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sheetal Pharmaceuticals?
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajni Goel  | Director | 18-Mar-1996 | Current |
| Shital Agrawal | Director | 20-Apr-2019 | Current |
| Nisha Devi | Director | 18-Mar-1996 | Current |
| Ramesh Goel | Director | 02-Apr-2012 | Current |
| Ruchi Goel | Director | 26-Mar-2015 | Current |
| Subhash Agrawal | Director | 26-Mar-2015 | Current |
Financial Performance of Sheetal Pharmaceuticals.
Sheetal Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.52% increase. The company also saw a slight decrease in profitability, with a 1.38% decrease in profit. The company's net worth Soared by an impressive increase of 25.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sheetal Pharmaceuticals?
In 2020, Sheetal Pharmaceuticals had a promoter holding of 87.56% and a public holding of 12.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Soar Pharmacia Private LimitedActive 16 years 6 monthsShital Agrawal and Ramesh Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Nov 2023 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 30 Dec 2020 | ₹0.81 M | Open |
Lucknow Khsetriya Gramin Bank Sponsored By Allahabad Bank Creation Date: 04 Apr 2008 | ₹1.00 M | Open |
How Many Employees Work at Sheetal Pharmaceuticals?
Sheetal Pharmaceuticals has a workforce of 3 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sheetal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sheetal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
